Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 381

1.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
[PubMed - indexed for MEDLINE]
2.

Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.

Suwantika AA, Tu HA, Postma MJ.

Vaccine. 2013 Jul 11;31(32):3300-7. doi: 10.1016/j.vaccine.2013.04.055. Epub 2013 May 21.

PMID:
23707163
[PubMed - indexed for MEDLINE]
3.

Cost-effectiveness of Rotavirus vaccination in Vietnam.

Kim SY, Goldie SJ, Salomon JA.

BMC Public Health. 2009 Jan 21;9:29. doi: 10.1186/1471-2458-9-29.

PMID:
19159483
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
[PubMed - indexed for MEDLINE]
5.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

PMID:
18664280
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.

Abbott C, Tiede B, Armah G, Mahmoud A.

Vaccine. 2012 Mar 28;30(15):2582-7. doi: 10.1016/j.vaccine.2012.01.076. Epub 2012 Feb 7.

PMID:
22321664
[PubMed - indexed for MEDLINE]
7.

Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Patel HD, Roberts ET, Constenla DO.

Vaccine. 2013 Dec 9;31(51):6072-8. doi: 10.1016/j.vaccine.2013.10.022. Epub 2013 Oct 29.

PMID:
24176497
[PubMed - indexed for MEDLINE]
8.

Economic evaluations of rotavirus immunization for developing countries: a review of the literature.

Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ.

Expert Rev Vaccines. 2011 Jul;10(7):1037-51. doi: 10.1586/erv.11.65. Review.

PMID:
21806398
[PubMed - indexed for MEDLINE]
9.

Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.

Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, Barry M.

Vaccine. 2011 Oct 6;29(43):7463-73. doi: 10.1016/j.vaccine.2011.07.056. Epub 2011 Aug 5.

PMID:
21821085
[PubMed - indexed for MEDLINE]
10.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.

PMID:
16235169
[PubMed - indexed for MEDLINE]
Free Article
11.

Health and economic impact of rotavirus vaccination in GAVI-eligible countries.

Kim SY, Sweet S, Slichter D, Goldie SJ.

BMC Public Health. 2010 May 14;10:253. doi: 10.1186/1471-2458-10-253.

PMID:
20470426
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cost-effectiveness of childhood rotavirus vaccination in Taiwan.

Wu CL, Yang YC, Huang LM, Chen KT.

Vaccine. 2009 Mar 4;27(10):1492-9. doi: 10.1016/j.vaccine.2009.01.023. Epub 2009 Jan 30.

PMID:
19186200
[PubMed - indexed for MEDLINE]
13.

Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.

Atherly D, Dreibelbis R, Parashar UD, Levin C, Wecker J, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S28-38. doi: 10.1086/605033.

PMID:
19817610
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

Standaert B, Parez N, Tehard B, Colin X, Detournay B.

Appl Health Econ Health Policy. 2008;6(4):199-216. doi: 10.2165/00148365-200806040-00003.

PMID:
19382820
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.

Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.

J Med Econ. 2011;14(6):748-58. doi: 10.3111/13696998.2011.614303. Epub 2011 Sep 15.

PMID:
21919673
[PubMed - indexed for MEDLINE]
16.

Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule.

Milne RJ, Grimwood K.

Value Health. 2009 Sep;12(6):888-98. doi: 10.1111/j.1524-4733.2009.00534.x. Epub 2009 Mar 18.

PMID:
19490550
[PubMed - indexed for MEDLINE]
17.

Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.

Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P.

Vaccine. 2012 Apr 16;30(18):2839-47. doi: 10.1016/j.vaccine.2012.02.047. Epub 2012 Mar 2.

PMID:
22387220
[PubMed - indexed for MEDLINE]
18.

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.

Shim E, Galvani AP.

Vaccine. 2009 Jun 19;27(30):4025-30. doi: 10.1016/j.vaccine.2009.04.030. Epub 2009 May 3.

PMID:
19389452
[PubMed - indexed for MEDLINE]
19.

Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.

Weycker D, Sofrygin O, Kemner JE, Pelton SI, Oster G.

Vaccine. 2009 Aug 6;27(36):4930-7. doi: 10.1016/j.vaccine.2009.06.025. Epub 2009 Jun 23.

PMID:
19555715
[PubMed - indexed for MEDLINE]
20.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk